This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove companies eli-lilly-co
article thumbnail

Why DICE Therapeutics Stock Is Soaring Tuesday

Benzinga

JUNE 20, 2023

DICE Therapeutics Inc (NASDAQ: DICE ) shares are trading higher Tuesday after Eli Lilly And Co (NYSE: LLY ) agreed to acquire the company. The Details: DICE Therapeutics and Eli Lilly announced a definitive agreement under which Eli Lilly will commence a tender offer to acquire all outstanding shares of DICE for $48 per.

52
52
article thumbnail

Eli Lilly To Acquire Small Company DICE Therapeutics Focused On Autoimmune Diseases For $2B

Benzinga

JUNE 20, 2023

Eli Lilly And Co (NYSE: LLY ) has agreed to acquire DICE Therapeutics Inc (NASDAQ: DICE ), a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop oral therapeutic candidates for immunology indications.

Technology 52
Technology 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs

Benzinga

DECEMBER 4, 2023

Roche Holding AG (OTC: RHHBY ) has agreed to acquire a privately held obesity company Carmot Therapeutics , seeking to challenge the dominance of weight-loss drugs from Novo Nordisk A/S (NYSE: NVO ) and Eli Lilly And Co (NYSE: LLY ).

59
59
article thumbnail

Point Biopharma Investor Sues For Info On Lilly's $1.4B Buy

Law 360 M&A

NOVEMBER 9, 2023

has sued the Indiana radiopharmaceutical company in Delaware's Court of Chancery, seeking to inspect its books and records in connection with its $1.4 billion plan to merge with Eli Lilly and Co. A shareholder of Point Biopharma Global Inc.

40
40
article thumbnail

Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On

Benzinga

JUNE 29, 2023

Sigilon Therapeutics Inc (NASDAQ: SGTX ) shares are skyrocketing after Eli Lilly And Co (NYSE: LLY ) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of approximately $34.6 per share in.

52
52
article thumbnail

Eli Lilly Resets Merger Review Clock On $2.4B Deal

Law 360 M&A

JULY 25, 2023

Pharmaceutical giant Eli Lilly & Co. billion deal for biopharmaceutical company Dice Therapeutics Inc. has given enforcers more time to review its planned $2.4 and also gave Dice's investors additional time to consider the offer.

40
40
article thumbnail

Eli Lilly Buying Obesity Drugmaker Versanis In Near-$2B Deal

Law 360 M&A

JULY 14, 2023

Kirkland & Ellis LLP-led pharmaceutical company Eli Lilly and Co. said Friday it has agreed to buy Versanis Bio, a clinical-stage biopharmaceutical company advised by Goodwin Procter LLP, for up to roughly $1.9 billion in cash.

40
40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024